Goldman Sachs’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $346K | Sell |
|
|||||
|
2021
Q4 | $1.18M | Buy |
|
|||||
|
2021
Q3 | $193K | Sell |
|
|||||
|
2021
Q2 | $244K | Buy |
|
|||||
|
2021
Q1 | $252K | Buy |
|
|||||
|
2020
Q4 | $231K | Buy |
|
|||||
|
2020
Q3 | $266K | Sell |
|
|||||
|
2020
Q2 | $335K | Buy |
|
|||||
|
2020
Q1 | $129K | Buy |
|
|||||
|
2019
Q4 | $181K | Buy |
|
|||||
|
2019
Q3 | $256K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $675K | Buy |
|